FDAFDA · Food and drugs·Recall number D-0088-2023
Quinapril Tablets USP, 40 mg (90 pack), Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, by: Lupin Limited, Goa 403 722 India, NDC# 68180-554-09
Published December 28, 2022 · Recall initiated: December 7, 2022
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations: Detection of N-Nitroso-quinapril impurity above the acceptable daily intake limit.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- QUINAPRIL
- Manufacturer
- Lupin Pharmaceuticals Inc.
- Distributor
- Product was distributed by major distribution chains nationwide.
- UPC
- 0368180559092
- Lot
- Lot #: G100533, G100534, Exp. 12/2022; G203071, Exp. 03/2024
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.